Copyright
©The Author(s) 2020.
World J Gastroenterol. May 21, 2020; 26(19): 2349-2373
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2349
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2349
Table 1 Abdominal and lymph node metastases in the miR-301a overexpression group are significantly increased
| MiR-301a | NC | P value | |
| Mouse weight (g) | 20.90 ± 2.42 | 20.07 ± 1.58 | 0.42 |
| Tumor weight (g) | 1.96 ± 0.93 | 2.37 ± 0.87 | 0.36 |
| Incidence of ascites | 6/10 | 3/9 | 0.483 |
| Abdominal metastasis | 9/10 | 2/9 | 0.012 |
| Liver metastasis | 2/10 | 2/9 | 1.000 |
| Pulmonary metastasis | 2/10 | 1/9 | 1.000 |
| Lymph node metastases | 5/10 | 0/10 | 0.039 |
- Citation: Zhang KD, Hu B, Cen G, Yang YH, Chen WW, Guo ZY, Wang XF, Zhao Q, Qiu ZJ. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer. World J Gastroenterol 2020; 26(19): 2349-2373
- URL: https://www.wjgnet.com/1007-9327/full/v26/i19/2349.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i19.2349